Try our business solution for free!

Delinquency trend drugs and pharmaceutical industry India 2017-2020

Published by
Sanyukta Kanwal,
Apr 14, 2022
From 2017 to 2020, share of non-performing assets (NPAs) in the drug and pharmaceuticals industry in India has seen a gradual decline every quarter. As of February 2020, the NPAs of the industry stood at 9.5 percent with a decline of over three percent within a year's span.

Delinquency trend drugs and pharmaceutical industry in India from March 2017 to February 2020

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2020

Region

India

Survey time period

March 2017 to February 2020

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Norway "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical industry in Norway

Overview

5

Pharmaceutical revenue

5

Production and trade

4

R&D, patents and new products

4

Further related statistics

11

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu